BP000421-HCV-206: Recombinant HCV NS5 Genotype-1a (2322-2423)
Source: E. coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-219: Recombinant HCV NS5 Genotype-1
Source: E. coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-227: Recombinant HCV NS5 Genotype-1a
Source: E. coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-228: Recombinant HCV NS5 Genotype-1b
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-229: Recombinant HCV NS5 Genotype-2
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-230: Recombinant HCV NS5 Genotype-2a
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-231: Recombinant HCV NS5 Genotype-2b
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-221: Recombinant HCV NS5 Genotype-3
Source: E. coli-derived.
Purity >95%, as determined by 10% PAGE (coomassie staining).
Specificty:Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000421-HCV-232: Recombinant HCV NS5 Genotype-3a
Source: E. coli-derived.
Purity >95%, as determined by 10% PAGE (coomassie staining).
Specificty:Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000421-HCV-233: Recombinant HCV NS5 Genotype-3b
Source: E. coli-derived.
Purity >95%, as determined by 10% PAGE (coomassie staining).
Specificty:Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.